Analysis of tumor microenvironment‐related key mRNAs and construction of a prognosis signature in colon cancer

Por Zhang, Zhiyuan, He, Guodong, Feng, Qingyang, Zheng, Peng, Lv, Yang, Mao, Yihao, Xu, Yuqiu, Xu, Jianmin
Publicado no Clin Transl Med (2020)

Timing of Hepatectomy for Resectable Synchronous Colorectal Liver Metastases: For Whom Simultaneous Resection Is More Suitable - A Meta-Analysis

Por Feng, Qingyang, Wei, Ye, Zhu, Dexiang, Ye, Lechi, Lin, Qi, Li, Wenxiang, Qin, Xinyu, Lyu, Minzhi, Xu, Jianmin
Publicado em 2014

A specific KRAS codon 13 mutation is an independent predictor for colorectal cancer metachronous distant metastases

Por Feng, Qingyang, Liang, Li, Ren, Li, Chen, Jingwen, Wei, Ye, Chang, Wenju, Zhu, Dexiang, Lin, Qi, Zheng, Peng, Xu, Jianmin
Publicado no Am J Cancer Res (2015)

High MICB expression as a biomarker for good prognosis of colorectal cancer

Por Feng, Qingyang, Yu, Shanchao, Mao, Yihao, Ji, Meiling, Wei, Ye, He, Guodong, Chang, Wenju, Zhu, Dexiang, Ren, Li, Xu, Jianmin
Publicado no J Cancer Res Clin Oncol (2020)

Small Nuclear Ribonucleoprotein Polypeptide N Accelerates Malignant Progression and Poor Prognosis in Colorectal Cancer Transcriptionally Regulated by E2F8

Por Ji, Meiling, Ren, Li, Lv, Yang, Lao, Xinyuan, Feng, Qingyang, Tang, Wentao, Zhuang, Aobo, Liu, Tianyu, Zheng, Peng, Xu, Jianmin
Publicado no Front Oncol (2020)

Significance of Surgery in the Treatment of Colorectal Cancer Ovarian Metastases: A Retrospective Case Matching Study

Por Xu, Yuqiu, Feng, Qingyang, Chen, Yijiao, Mao, Yihao, Zhang, Zhiyuan, Lv, Yang, Zheng, Peng, Yu, Shanchao, He, Guodong, Xu, Jianmin
Publicado no Cancer Manag Res (2021)

Open Right Hemicolectomy:Lateral to Medial or Medial to Lateral Approach?

Por Xu, Pingping, Ren, Li, Zhu, Dexiang, Lin, Qi, Zhong, Yunshi, Tang, Wentao, Feng, Qingyang, Zheng, Peng, Ji, Meiling, Wei, Ye, Xu, Jianmin
Publicado no PLoS One (2015)

Silencing homeobox C6 inhibits colorectal cancer cell proliferation

Por Ji, Meiling, Feng, Qingyang, He, Guodong, Yang, Liangliang, Tang, Wentao, Lao, Xinyuan, Zhu, Dexiang, Lin, Qi, Xu, Pingping, Wei, Ye, Xu, Jianmin
Publicado no Oncotarget (2016)

The mechanism of the premetastatic niche facilitating colorectal cancer liver metastasis generated from myeloid-derived suppressor cells induced by the S1PR1–STAT3 signaling pathwa...

Por Lin, Qi, Ren, Li, Jian, Mi, Xu, Pingping, Li, Jun, Zheng, Peng, Feng, Qingyang, Yang, Liangliang, Ji, Meilin, Wei, Ye, Xu, Jianmin
Publicado no Cell Death Dis (2019)

Determinants of Long-Term Outcome in Patients Undergoing Simultaneous Resection of Synchronous Colorectal Liver Metastases

Por Lin, Qi, Ye, Qinghai, Zhu, Dexiang, Wei, Ye, Ren, Li, Ye, Lechi, Feng, Qingyang, Xu, Pingping, Zheng, Peng, Lv, Minzhi, Fan, Jia, Xu, Jianmin
Publicado em 2014

Differences in clinical characteristics and mutational pattern between synchronous and metachronous colorectal liver metastases

Por Zheng, Peng, Ren, Li, Feng, Qingyang, Zhu, Dexiang, Chang, Wenju, He, Guodong, Ji, Meiling, Jian, Mi, Lin, Qi, Yi, Tuo, Wei, Ye, Xu, Jianmin
Publicado no Cancer Manag Res (2018)

Patients with RAS wild-type right-sided unresectable liver-confined mCRC also benefit from cetuximab plus chemotherapy in first-line treatment

Por Zheng, Peng, Ren, Li, Feng, Qingyang, Zhu, Dexiang, Chang, Wenju, He, Guodong, Ji, Meiling, Jian, Mi, Lin, Qi, Yi, Tuo, Wei, Ye, Xu, Jianmin
Publicado no Am J Cancer Res (2018)

Low tumor purity is associated with poor prognosis, heavy mutation burden, and intense immune phenotype in colon cancer

Por Mao, Yihao, Feng, Qingyang, Zheng, Peng, Yang, Liangliang, Liu, Tianyu, Xu, Yuqiu, Zhu, Dexiang, Chang, Wenju, Ji, Meiling, Ren, Li, Wei, Ye, He, Guodong, Xu, Jianmin
Publicado no Cancer Manag Res (2018)

Efficacy of continued cetuximab for unresectable metastatic colorectal cancer after disease progression during first-line cetuximab-based chemotherapy: a retrospective cohort study

Por Feng, Qingyang, Wei, Ye, Ren, Li, Zheng, Peng, Yu, Yiyi, Ye, Qinghai, Ding, Jianyong, Chen, Jingwen, Chang, Wenju, Zhong, Yunshi, Zhu, Dexiang, Lin, Qi, Yang, Liangliang, Qin, Xinyu, Xu, Jianmin
Publicado no Oncotarget (2016)

Additional Biomarkers beyond RAS That Impact the Efficacy of Cetuximab plus Chemotherapy in mCRC: A Retrospective Biomarker Analysis

Por Zheng, Peng, Liang, Chunmin, Ren, Li, Zhu, Dexiang, Feng, Qingyang, Chang, Wenju, He, Guodong, Ye, Lechi, Chen, Jingwen, Lin, Qi, Yi, Tuo, Ji, Meiling, Niu, Zhengchuan, Jian, Mi, Wei, Ye, Xu, Jianmin
Publicado no J Oncol (2018)